Abiraterone Acetate

Generic name

Abiraterone Acetate

Covered by Medicare

Yes

Get a Medicare Quote

Average Annual Cost per Beneficiary

$19,704.08

Average cost per year*

Average Annual Cost per Dose

$33.68

16.23%

Average cost per beneficiary*

Manufacturer(s)

  • Bluepoint/Oncop
  • Mylan
  • Novadoz Pharmac
  • Northstar Rx Ll
  • Dr.Reddy'S Lab
  • Wockhardt USA L
  • Celltrion USA,
  • Major Pharmaceu
  • Rising Pharm
  • Avkare
  • Glenmark Pharma
  • West-Ward/Hikma
  • Teva USA
  • Patriot Pharmac
  • Amneal Pharmace
  • Mylan Instituti
  • Apotex Corp

What is Abiraterone Acetate

This medication is used to treat prostate cancer. Abiraterone belongs to a class of drugs known as anti-androgens (anti-testosterone). Testosterone, a natural hormone, helps prostate cancer to grow and spread. Abiraterone works by blocking the production of testosterone, thereby slowing the growth and spread of prostate cancer. This medication should not be given to women or children. NOTE: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.

Drug Trends

*Origin of the terms and chart data used within this page: https://data.cms.gov/

Common Questions About Abiraterone Acetate

Yes, Abiraterone Acetate is covered by Medicare.

In 2021, the average cost per dose of Abiraterone Acetate was $33.68.

The average dose of Abiraterone Acetate received per year is 10,101,879 units

30,513 Medicare beneficiaries received Abiraterone Acetate in 2021, which was a 0.29% from 2020

There were 199,332 claims made by Medicare beneficiaries, which is a 0.31% from 2020

The average spending amount per claim in 2021 was $3,016.23

The average Medicare spending per beneficiary amount for Abiraterone Acetate was $19,704.08

The most expensive manufacturer of Abiraterone Acetate is Mylan

West-Ward/Hikma is the least expensive manufacturer with an Average Spending Per Dosage Unit of $1.58

Novadoz Pharmac received $233,618,611.16

The total amount spent on Abiraterone Acetate by Medicare is $601,230,706.57

© 2021-2023 HealthInsurance.com, LLC

Privacy Policy  |  Terms and Conditions

GENERAL DISCLAIMERS

Healthinsurance.com is a commercial site designed for the solicitation of insurance from selected health insurance carriers and HealthInsurance.com, LLC is a licensed insurance agency. It is not a government agency. It is also not an insurer, or a medical provider. HealthInsurance.com, LLC is a licensed representative of Medicare Advantage (HMO, PPO, PFFS, and PDP) organizations that have a Medicare contract. Enrollment depends on the plan’s contract renewal.

We do not offer every plan available in your area. Currently we represent nine carrier plan organizations nationally. Please contact Medicare.gov, 1-800-MEDICARE, or your local State Health Insurance Program (SHIP) to get information on all of your options.

Alternatively, you may be referred, via a link, to a selected partner website, which is independently owned and operated and may have different privacy and terms of use policies from us.

If you provide your contact information to us, an insurance agent/producer or insurance company may contact you. If you do not speak English, language assistance service, free of charge, is available to you; contact the toll-free number listed above. This site is not maintained by or affiliated with the federal government's Health Insurance Marketplace website or any state government health insurance marketplace.

The plans we represent do not discriminate on the basis of race, color, national origin, age, disability, or sex. To learn more about a plan's nondiscrimination policy, please click here.

Not all plans offer all of these benefits. Benefits may vary by carrier and location. Limitations and exclusions may apply.

Multi-Plan_HIC_Web_M